Background: Tuberculosis is a major cause of death in India. Premature cessation of treatment in tuberculosis patient is a leading cause for developing MDR (multidrug resistant tuberculosis) as well as a major threat to control programs. Despite the easy approach and free of cost, availability to antitubercular medicines the interruptions of the treatment are still on a high. So, we analyzed such various reasons leading to interrupt the antitubercular treatment.Methods: Total 150 patients who interrupted the antitubercular treatment, were interviewed with a predesigned questionnaire and the result was analyzed.Results: Out of total 150 patients 115 (76.7%) male and 35 (23.3%) female were interviewed, who were having history of antitubercular treatment interruption. Out of 150 patients, 79 (52.7%) patients stopped their treatment because of improvement. Total 25 (16.7%) patients had stopped their treatment because of high cost, 16 (10.7%) due to personal/family reason, 17 (11.4%) patients had stopped their treatment due to nausea/vomiting/anorexia, 5 (3.3%) due to alcoholism/drug or other addiction, 2 (1.3%) patients had stopped their treatment because they were advised to stop it by health personnel and long distance travelled to take drugs.Conclusions: Improvement of symptoms was the most common reason in patients who received DOTS treatment and high cost of treatment in patients who received non DOTS treatment. Poor education and socioeconomic status of society are the other reasons for possible treatment interruptions because as soon as the patient improves, they move out to earn their wages to run the family with the unavoidable default from the treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.